RBC Capital raised the firm’s price target on Celestica (CLS) to $75 from $65 and keeps an Outperform rating on the shares. The company delivered another solid beat and raise with its Q3 results, and while FY25 revenue guidance was just in line with consensus, upside is likely given its management’s typical conservatism, the analyst tells investors in a research note. With increasing visibility to long-term growth and profitability, Celestica’s valuation is likely to continue to re-rate upwards, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLS:
- Celestica reports Q3 EPS $1.04 vs. 65c last year
- Celestica sees Q4 EPS 99c-$1.09, consensus 95c
- Celestica raises FY24 EPS view to $3.85 from $3.62, consensus $3.65
- Celestica sees FY25 EPS $4.42, consensus $4.07
- Celestica Reports Strong Q3 2024 Financial Results
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
